BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 18370854)

  • 1. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials.
    Strimpakos AS; Sharma RA
    Antioxid Redox Signal; 2008 Mar; 10(3):511-45. PubMed ID: 18370854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin: the story so far.
    Sharma RA; Gescher AJ; Steward WP
    Eur J Cancer; 2005 Sep; 41(13):1955-68. PubMed ID: 16081279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of curcumin.
    Sharma RA; Steward WP; Gescher AJ
    Adv Exp Med Biol; 2007; 595():453-70. PubMed ID: 17569224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy.
    Mahran RI; Hagras MM; Sun D; Brenner DE
    AAPS J; 2017 Jan; 19(1):54-81. PubMed ID: 27783266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
    Shehzad A; Wahid F; Lee YS
    Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin and neurodegenerative diseases: a perspective.
    Darvesh AS; Carroll RT; Bishayee A; Novotny NA; Geldenhuys WJ; Van der Schyf CJ
    Expert Opin Investig Drugs; 2012 Aug; 21(8):1123-40. PubMed ID: 22668065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of curcumin: problems and promises.
    Anand P; Kunnumakkara AB; Newman RA; Aggarwal BB
    Mol Pharm; 2007; 4(6):807-18. PubMed ID: 17999464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
    Jurenka JS
    Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin: a novel therapeutic for burn pain and wound healing.
    Cheppudira B; Fowler M; McGhee L; Greer A; Mares A; Petz L; Devore D; Loyd DR; Clifford JL
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1295-303. PubMed ID: 23902423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Applications of Curcumin Nanoformulations.
    Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
    AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin therapeutic promises and bioavailability in colorectal cancer.
    Shehzad A; Khan S; Shehzad O; Lee YS
    Drugs Today (Barc); 2010 Jul; 46(7):523-32. PubMed ID: 20683505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular understanding of curcumin in diabetic nephropathy.
    Soetikno V; Suzuki K; Veeraveedu PT; Arumugam S; Lakshmanan AP; Sone H; Watanabe K
    Drug Discov Today; 2013 Aug; 18(15-16):756-63. PubMed ID: 23651956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives.
    Tsuda T
    Food Funct; 2018 Feb; 9(2):705-714. PubMed ID: 29206254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer.
    Heger M; van Golen RF; Broekgaarden M; Michel MC
    Pharmacol Rev; 2014; 66(1):222-307. PubMed ID: 24368738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular protection by curcumin: molecular aspects.
    Kapakos G; Youreva V; Srivastava AK
    Indian J Biochem Biophys; 2012 Oct; 49(5):306-15. PubMed ID: 23259317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin nanomedicine: a road to cancer therapeutics.
    Yallapu MM; Jaggi M; Chauhan SC
    Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
    Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
    Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is curcumin bioavailability a problem in humans: lessons from clinical trials.
    Kunnumakkara AB; Harsha C; Banik K; Vikkurthi R; Sailo BL; Bordoloi D; Gupta SC; Aggarwal BB
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):705-733. PubMed ID: 31361978
    [No Abstract]   [Full Text] [Related]  

  • 19. Curcumin, a component of turmeric: from farm to pharmacy.
    Gupta SC; Kismali G; Aggarwal BB
    Biofactors; 2013; 39(1):2-13. PubMed ID: 23339055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in curcumin nanoformulation for cancer therapy.
    Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.